Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to accelerating promising treatments, has announced enrollment of the first two patients in the highly anticipated study of DB107 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback